No problem.
The results must be provided to the minister no later than one year after the completion, with all results being reported for trials or tests that involved human subjects, and that results of clinical trials and tests must be provided to the minister, even if no authorization is issued within six months.
The next part of the amendment deals with publicly disclosing information on Health Canada's website, such as all clinical trials and investigational tests and the results; decisions respecting the issuance or refusal of authorizations and reasons; terms and conditions imposed on an authorization, as well as decisions respecting suspensions and revocations of authorizations and the reasons; the recalls of a therapeutic product and the reasons; and information about any serious adverse drug reactions. There is also a protection that any information cannot be issued to gain an unfair commercial advantage.
This amendments bring transparency to the clinical trial process and the decisions Health Canada makes in regard to issuing authorizations, safety warnings, or recalls, and the reasons for them by ensuring that this information is available on Health Canada's website.